NanoEnTek Inc
KOSDAQ:039860
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NanoEnTek Inc
Cash from Operating Activities
NanoEnTek Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NanoEnTek Inc
KOSDAQ:039860
|
Cash from Operating Activities
₩929.5m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Cash from Operating Activities
₩2.2T
|
CAGR 3-Years
33%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Cash from Operating Activities
-₩4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Cash from Operating Activities
-₩20.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Cash from Operating Activities
₩14B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Cash from Operating Activities
-₩124.5B
|
CAGR 3-Years
-159%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-31%
|
|
NanoEnTek Inc
Glance View
NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NanoEnTek Inc's Cash from Operating Activities?
Cash from Operating Activities
929.5m
KRW
Based on the financial report for Sep 30, 2025, NanoEnTek Inc's Cash from Operating Activities amounts to 929.5m KRW.
What is NanoEnTek Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-32%
The average annual Cash from Operating Activities growth rates for NanoEnTek Inc have been -47% over the past three years , -32% over the past five years .
